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Sarcopenia is the drastic loss of skeletal muscle mass and strength during ageing. In order to
better understand the molecular pathogenesis of age-related muscle wasting, we have performed
a DIGE analysis of young adult versus old rat skeletal muscle. Proteomic profiling revealed that
out of 2493 separated 2-D spots, 69 proteins exhibited a drastically changed expression. Age-de-
pendent alterations in protein abundance indicated dramatic changes in metabolism, contractile
activity, myofibrillar remodelling and stress response. In contrast to decreased levels of pyruvate
kinase (PK), enolase and phosphofructokinase, the mitochondrial ATP synthase, succinate
dehydrogenase, malate dehydrogenase, isocitrate dehydrogenase and adenylate kinase (AK) were
increased in senescent fibres. Higher expression levels of myoglobin and fatty acid binding-pro-
tein indicated a shift to more aerobic-oxidative metabolism in a slower-twitching aged fibre pop-
ulation. The drastic increase in aB-crystallin and myotilin demonstrated substantial filament
remodelling during ageing. An immunoblotting survey of selected muscle proteins confirmed
the pathobiochemical transition process in aged muscle metabolism. The proteomic analysis of
aged muscle has identified a large cohort of new biomarkers of sarcopenia including opposite
changes in PK and AK, which might be useful for the design of improved diagnostic procedures
and/or therapeutic strategies to counteract ageing-induced muscle degeneration.
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1 Introduction
Since low skeletal muscle mass in older persons is clearly
associated with severe functional impairment and physical
disability [1], it is important to elucidate the molecular and
cellular mechanisms underlying age-related muscle wasting
[2–5]. The biochemical identification of new disease markers
of sarcopenia may lead to the development of improved di-
agnostic methods or the design of novel treatment strategies
to eliminate the age-induced loss of skeletal muscle fibres [6].
Sarcopenia occurs in all individuals to some degree as a
consequence of ageing, but it can be accelerated by a variety
of factors including inactivity, poor nutrition and chronic ill-
ness [7]. For the investigation of neuromuscular diseases, it
is important to take into account that the metabolic and
contractile properties of skeletal muscle fibres are dependent
on patterns of innervation and activity [8]. Long-term inac-
tivity inevitably results in disuse atrophy triggering a dra-
matic loss of muscle mass and contractile force. Severe
forms of sarcopenia may prevent older individuals from liv-
ing a normal life and may make them dependent on outside
help despite the lack of other medical problems. Large cross-
sectional studies have attempted to quantify the age-asso-
ciated decline in skeletal muscle mass [9–11]. Although dif-
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ferent analytical techniques lead to varying results in the
extent of the loss of lean muscle mass, the decline in muscle
mass appears to be approximately 15–42% between the ages
of 20 and 80 [12]. Importantly, studies that have corrected for
the loss in skeletal muscle mass in the age-dependent
decline in skeletal muscle strength, suggest that the reduc-
tion in the efficiency of muscle strength per muscle mass is
even more pronounced [13].
However, conclusions drawn from patient studies into
the loss of muscle mass or the decline in muscle strength are
complicated by various biomedical factors. Results from the
analysis of muscle specimens from younger versus older
individuals may be tainted if the general environments,
including lifestyle differences, food habits and activity pat-
terns, were fundamentally different for historical reasons [9–
13]. Thus, initial surveys for the biochemical identification of
novel biomarkers of age-related muscle wasting should be
performed by small-scale animal model proteomics instead
of extensive clinical studies [14]. Since human muscle speci-
mens usually exhibit a high degree of interindividual differ-
ences [15], it is advantageous to perform comparative inves-
tigations with suitable model systems of cellular ageing [14].
Rodent skeletal muscle fibres, especially rat muscle, have
been widely accepted as a suitable animal model for studying
sarcopenia of old age [16–18]. Besides being essential for
identifying new biomarkers, the biochemical characteriza-
tion of the rat model of sarcopenia is also useful for pheno-
typing purposes. Once an animal model of a specific neuro-
muscular disease has been extensively surveyed, this biolog-
ical knowledge can be exploited in subsequent experimental
treatment studies such as gene replacement or stem cell
therapy [14]. Differential 2-DE techniques [19] in combina-
tion with high-throughput MS analysis [20] suggest them-
selves for a comprehensive analysis of the aged skeletal
muscle proteome [21–24]. Because MS-based proteomics has
been widely applied to the cataloguing of skeletal muscle
proteins [25–29], the results from new studies on neuro-
muscular disease processes can be compared to extensive
reference maps of the soluble muscle proteome [14]. Fluo-
rescence DIGE analysis represents one of the most advanced
biochemical tools for the proteomic profiling of two different
sets of protein complements [30], we therefore employed this
technique for the identification of new biomarkers of sarco-
penia. DIGE greatly reduces gel-to-gel variations [31] and
thereby improves the evaluation of trends in changed protein
expression patterns [32].
Here, we have used fluorescent tagging of 3-month- ver-
sus 30-month-old rat skeletal muscles in order to perform a
comprehensive gel electrophoresis-based survey of potential
changes in the protein expression pattern between young
adult and senescent fibres. The proteomic identification of
new biomarkers of sarcopenia may be useful for the inter-
pretation of the results from previous ageing studies [2–5].
The age-related muscle wasting pathology is extremely com-
plex and seems to affect a variety of essential cellular pro-
cesses, including protection from oxidative stress, main-
tenance of mitochondrial metabolism, proper microcircula-
tion, PTMs of key muscle proteins, hormonal balance, ion
homeostasis, regenerative potential and excitation–contrac-
tion coupling [33–38]. While alterations in certain muscle
proteins probably reflect a relatively nonspecific perturbation
of cellular metabolism due to fibre atrophy, other abundance
changes in key muscle proteins may indicate sarcopenia-
specific modifications. Since the reduction in skeletal muscle
mass and decrease in fibre strength has only recently been
recognized as a serious health threat for a large portion of
society [11], there is an urgent need for establishing proper
diagnostic markers for the clinical evaluation of this mus-
cular disorder. Besides individual protein species with a
drastically modified density in ageing, also the combination
of alterations in several common protein biomarkers would
be a potential starting point to develop new diagnostic tools.
Following the densitometric determination of the differ-
ential expression pattern for 69 2-D protein spots, PMF
analysis identified 18 proteins as being decreased including
PK, pyruvate dehydrogenase, myosin binding protein C, car-
bonic anhydrase, enolase and phosphofructokinase, and 51
proteins being increased such as the mitochondrial ATP
synthase, succinate dehydrogenase (SDH), malate dehy-
drogenase (MDH), isocitrate dehydrogenase (IDH), adeny-
late kinase (AK), myoglobin, fatty acid binding protein
(FABP), aB-crystallin and myotilin. These findings suggest
that the biological changes associated with old age include
both generally perturbed protein expression pattern and
specific alterations in skeletal muscle fibres. With respect to
biogerontology and the potential to develop better treatments
to counteract sarcopenia, the most significant finding of this
study is probably the drastic decrease in PK and concomitant
increase in numerous mitochondrial marker enzymes, indi-
cating a shift towards a more aerobic-oxidativemetabolism in
aged muscle fibres. In addition, the increase in the small
heat shock protein aB-crystallin and myotilin suggest sub-
stantial remodelling of damaged filamentous elements. The
discovery that the enzymes AK and PK experience the oppo-
site pathobiochemical fate during muscle ageing might be
exploitable for the future design of a reliable assay to diag-
nose sarcopenia of old age.
2 Materials and methods
2.1 Materials
Electrophoresis-grade chemicals, the 2D-Quant kit for deter-
mination of protein concentration in electrophoretic sam-
ples, the 2D-Clean-Up kit for removal of contaminants prior
to IEF, CyDye DIGE fluor minimal dyes Cy2, Cy3 and Cy5,
CBB protein dye, IPG strips of pH 3–10 (linear), IPG buffer
of pH 3–10 for IEF and ACN were purchased from Amers-
ham Biosciences/GE Healthcare (Little Chalfont, Bucks.,
UK). For microscopy, the DNA-binding dye diamidino-phe-
nyindole (DAPI) and Superfrost Plus positively charged
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microscope slides were obtained from Sigma (Dorset, UK)
and Menzel Glässer (Braunschweig, Germany), respectively.
Ultrapure protogel acrylamide stock solutions was from
National Diagnostics (Atlanta, GA, USA). Sequencing grade-
modified trypsin for peptide generation was obtained from
Promega (Madison, WI, USA). A matrix kit containing
CHCA and the external peptide MS calibration kit Peptide-
mix-1 were from Laserbiolabs (Sophia-Antipolis, France).
Immobilon NC nitrocellulose membranes and chemilumi-
nescence substrates were purchased from Pierce and Warri-
ner (Chester, UK) and Millipore (Bedford, MA, USA). Pro-
tease inhibitors were from Roche Diagnostics (Mannheim,
Germany). Ultrapure lysine for quenching the DIGE label-
ling reaction, DNase-I enzyme, the presiliconization medi-
um Sigmacote, as well as all other analytical-grade chemicals
were purchased from Sigma Chemical Company.
2.2 Antibodies
Primary antibodies were obtained from Abcam, Cambridge,
UK (ab38237 to PK; ab2101 to lactate dehydrognase;
ab36329 to IDH; ab2872 to cardiac FABP), Santa Cruz Bio-
technology, Santa Cruz, CA, USA (ab-sc28785 to AK iso-
form AK1; ab-sc27992 to SDH), Abgent, San Diego, CA,
USA (pAb AP7094b to phosphoglycerate kinase 1); Abnova
Corporation, Niehu, Taipei, Taiwan (ab2B11-B7 to MDH).
Secondary peroxidase-conjugated secondary antibodies were
purchased from Chemicon International (Temecula, CA,
USA). For confocal laser scanning microscopy, Alexa Fluor-
conjugated secondary antibodies were obtained from Invi-
trogen Molecular Probes (Bio Sciences, Dun Laoghaire, Ire-
land).
2.3 Animal model of sarcopenia
Skeletal muscle fibres from 30-month-old Wister rats
represent an established animal model of sarcopenia of old
age [14]. Since a previous 2-DE analysis of rat muscle using
CBB R-250 [23] showed that 7-month-old muscle and 18-
month-old muscle exhibit more similar protein expression
pattern as compared to senescent fibres, the proteomic
study outlined here was performed with 3-month-old versus
30-month-old gastrocnemius muscle preparations. For
immunoblotting purposes, also 6-month-old muscle sam-
ples were used. Freshly dissected muscle specimens from
Wistar rats representing young adults versus old animals
were obtained from the Bioresource Facility of the Physiol-
ogy Department, Trinity College Dublin. Rat colonies were
kept at a standard light dark cycle and fed at libidum, as
previously described [39]. For the optimization of the 2-DE
separation of the soluble rat skeletal muscle proteome and
the fluorescent DIGE approach, an animal population of 15
young adult and 15 old Wistar rats was used. For individual
sets of DIGE analyses, six young samples, six old samples
and six pooled standards were prepared for the statistical
analysis of the electrophoretically separated rat muscle pro-
teome using six DIGE gels [40]. In addition, two pick gels
for the MS-based identification of individual 2-D muscle
protein spots were used.
2.4 Preparation of muscle protein extracts
The preparation, labelling and separation of skeletal muscle
proteins was carried out by optimized procedures, as pre-
viously described by our laboratory [40–43]. Equal amounts
of young adult and senescent gastrocnemius tissue (,150 mg
wet weight) were quick-frozen in liquid nitrogen and
ground-up into a fine powder using a mortar and pestle.
Following resuspension of the skeletal muscle powder in
1 mL of lysis buffer (7 M urea, 2 M thiourea, 4% w/v
CHAPS, 2% ampholytes pH 3–10, 100 mM DTT), 2 mL of
DNase-I (200 units) were added per 100 mL of extraction buf-
fer [43]. Otherwise the presence of DNA can lead to excessive
viscosity causing problems with the accurate pipetting and
transfer of liquid protein aliquotes. In addition, to prevent
the proteolytic degradation of sensitive muscle proteins, the
extraction medium was supplemented with a previously
optimized protease inhibitor cocktail (0.15 mM aprotinin,
0.3 mM E-64, 1 mM leupetin, 0.2 mM pefabloc, 1.4 mM pep-
statin, 0.5 mM soybean trypsin inhibitor, 1 mM EDTA) [44].
The subsequent incubation, mixing, centrifugation, ultra-
sonnication, desalting and rehydration steps were performed
by standard methods [41]. Determination of protein con-
centration and removal of potentially interfering contami-
nants was carried out with the 2D-Quant kit and 2D-Clean-
Up kit from Amersham Biosciences/GE Healthcare, respec-
tively. Finally, protein pellets representing young adult and
old skeletal muscle protein fractions were resuspended in
DIGE lysis buffer (7 M urea, 2 M thiourea, 30 mM Tris, 4%
CHAPS, pH 8.5) and adjusted to a protein concentration of
1 mg/mL [40].
2.5 DIGE labelling of muscle protein extracts
For comparative proteomic profiling, 50 mg protein aliquotes
from young adult, senescent and pooled internal standards
were labelled with 200 rmol Cy3 dye, Cy5 dye and Cy2 dye,
respectively, for 30 min on ice and in the dark. As outlined in
a recent statistical analysis of the experimental variation of
the DIGE technique by Corzett et al. [45], selective labelling
artefacts do not appear to play a role in the case of soluble
protein species. Therefore, reverse DIGE labelling controls
are not routinely employed. In our experience, dye to dye
variability is minimal and the findings from expression
analyses with different dye combinations do not differ sig-
nificantly. The dye labelling of skeletal muscle proteins has
been previously optimized by our laboratory [40], which
included the determination of the most economical protein/
dye ratio. Protein lysates were treated with the 2D-Clean-Up
kit from Amersham Biosciences/GE Healthcare prior to the
labelling with Cy dyes. Quenching of the fluorescent label-
ling reaction was carried out with 10 mM lysine for 10 min
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on ice. Labelled muscle protein extracts were pooled together
and gently mixed with an equal volume of 26sample buffer
(7 M urea, 2 M thiourea, 4% CHAPS, 2% IPG Buffer pH 3–
10,130 mM DTT). The suspension was left on ice for 10 min
and used immediately for 2-DE separation.
2.6 2-DE separation of muscle extracts
Standard 2-DE with IEF in the first dimension and SDS-
PAGE in the second dimension was employed to separate
the differentially labelled muscle protein fractions [43]. A
reswelling tray from Amersham Biosciences/GE Healthcare
was used to rehydrate IPG strips pH 3–10 (linear) for 12 h
with 0.45 mL of rehydration buffer (7 M urea, 2 M thiourea,
4% w/v CHAPS, 30 mM Tris, pH 8.5) containing 0.05%
bromophenol blue. IEF strips were run on an IPGphor IEF
system from Amersham Biosciences/GE Healthcare for a
total of 66 500 V?h [40]. After equilibration, an Ettan Dalt-
Twelve system (Amersham Biosciences/GE Healthcare) with
12.5% resolving gels was used for the second-dimensional
separation of fluorescently labelled skeletal muscle proteins
[43]. Following electrophoretic separation at 0.2 W/gel for 1 h
and at 0.4 W/gel for 1 h, gels were ran at 1.5 W/gel overnight.
Next morning, slab gel electrophoresis was terminated when
the tracking dye had just run off the lower edge of the gel.
2.7 Protein expression analysis
A Typhoon Trio variable mode imager system from Amers-
ham Biosciences/GE Healthcare was used to visualize fluo-
rescently labelled proteins. 2-D images from the Cy2-, Cy3-
and Cy5-labelled protein fractions were scanned using a 488,
532 and 633 nm laser, respectively [40]. Scanning was per-
formed at 100 mm resolution and PMT values for scanned
images was between 500 and 560 V. Gel images were crop-
ped using the ImageQuant TL software programme and gel
analysis was carried out with the DeCyder V6.0 2-D analysis
software package for DIGE (Amersham Biosciences/GE
Healthcare). The DeCyder differential in-gel analysis module
was employed for pairwise comparison of each young adult
versus old muscle sample to the pooled standard present in
each gel and for the calculation of normalized spot volume/
protein abundance. Using the DeCyder Biological Variation
Analysis module and Cy3:Cy2 and Cy5:Cy2 ratios for each
individual protein, datasets from six DIGE gels were taken to
calculate average abundance and paired Student’s t-test p-
values for muscle proteins. 2-D spots that exhibited a 1.8-fold
or more decrease or increase were then identified by PMF
analysis.
2.8 MS analysis
2-D muscle protein spots of interest, electrophoresed in
Coomassie-stained pick gels parallel to DIGE gels, were
washed, digested and identified by MALDI-ToF MS analysis
as previously optimized by our laboratory [40, 41, 43]. Gel
plugs were transferred to 1.5 mL Eppendorf tubes that had
been presiliconized with Sigmacote (Sigma Chemical Com-
pany) and were then destained, desalted and washed by
standard procedure [40]. Protein digestion was performed
for 60 min at 377C with a buffer containing 1 mg of trypsin
per 20 mL of 50 mM NH4HCO3. Excess enzyme solution was
removed and 3 mL of 50 mM NH4HCO3 was added to keep
gel pieces wet overnight. Following centrifugation, extrac-
tion, concentration and resuspension in 8mL of 3% v/v TFA
[43], individual peptide mixtures were stored at 2707C prior
to MS analysis. PMF-based identification of muscle proteins
by MALDI-ToF MS was carried out with peptide mixtures
that had been eluted onto the sample plate with a matrix
solution consisting of 5 mg/mL CHCA in 50% v/v ACN/
0.1% v/v trifluoroacetic. Mass spectra were recorded with an
Ettan MALDI-ToF Pro instrument from Amersham Bio-
sciences, operating in the positive reflector mode at the fol-
lowing parameters: accelerating voltage 20 kV; and pulsed
extraction: on (focus mass 2500) [40]. For external and
internal calibration, Peptidemix-1 from Laserbiolabs con-
taining peaks ranging from 1046.5 to 2465.10 m/z and
trypsin autolysis peaks at 221.104 and 842.50 m/z, respec-
tively, were used. Mass spectra were analysed with MALDI
evaluation software and skeletal muscle protein species
identified via the PMF ProFound search engine. All cer-
tainty hits of rat gastrocnemius muscle proteins, generated
by the ProFound search engine, were matched against the
publicly available search engine MASCOT from
Matrixscience.
2.9 Immunoblotting
In order to confirm changes in the expression levels of dis-
tinct muscle proteins, as revealed by DIGE analysis, 1-D and
2-D immunoblotting with highly specific primary antibodies
was employed. Following gel electrophoretic separation,
proteins were transferred at 100 V for 80 min to Immobilin
NC-pure nitrocellulose membranes with the help of a Trans-
blot Cell from BioRad Laboratories (Hemel Hempstead,
Herts., UK) [46]. Blots were blocked for 1 h in 50 mM
sodium phosphate, pH 7.4, 0.9% w/v NaCl, containing 5%
w/v fat-free milk powder. NC sheets were then incubated
with primary antibodies, washed, exposed to peroxidase-
conjugated secondary antibodies and washed again by
standard methods [47]. In order to visualize immuno-deco-
rated 2-D muscle protein spots, the SuperSignal ECL kit
from Pierce and Warriner was used. A Typhoon Trio variable
mode imager from Amersham Biosciences/GE Healthcare
with ImageQuant TL software was employed for the densi-
tometric scanning and evaluation of immunoblots.
2.10 Immunofluorescence microscopy
Confocal laser scanning microscopy was carried out as pre-
viously described in detail [40] using 10 mm-thick transverse
cryosections from young adult versus old gastrocnemius
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muscle. Tissue sections were mounted on Superfrost Plus
positively charged microscope slides and then quick-frozen,
fixed and blocked by standard methodology [47]. Following
incubation overnight at 47C with a primary antibodies, cryo-
sections were carefully washed, and then incubated for
30 min at 257C with secondary antibodies that had been
conjugated to Alexa Fluor 488 dye or Alexa Fluor 594 dye. An
Olympus FluoView FV1000 confocal laser scanning micro-
scope (Olympus Life and Material Science Europe, Ham-
burg, Germany) was employed for image acquisition using
the Olympus FluoView Version 1.3c software package. The
position of nuclei within muscle fibres was determined by
incubation with the DNA-binding dye DAPI [47]. In order to
outline the sarcolemma of individual muscle fibres, cryosec-
tions were labelled with antibodies to the dystrophin-asso-
ciated glycoprotein b-dystroglycan, using Alexa Fluor 594 dye
[40]. The labelling of PK was performed with Alexa Fluor dye
488.
3 Results
3.1 DIGE analysis of aged rat skeletal muscle
In contrast to staining with conventional protein dyes such
as CBB or silver, fluorescent tagging of the entire muscle
protein complement drastically increases the number of
detectable protein spots in standard 2-DE [20]. A previous
proteomic study of muscle ageing in the rat used CBB G-250
as a total protein dye and resulted in the detection of 564 in-
dividual 2-D spots [23]. The fluorescent DIGE analysis of
aged rat gastrocnemius muscle described here resulted in the
visualization of 2493 protein species. Hence, the DIGE-based
proteomic profiling study of aged fibres is approximately 4.4-
fold more sensitive as compared to conventional protein
labelling techniques. In addition, gel-to-gel variations in the
2-D protein distribution pattern are greatly reduced due to
running the two different proteomes and a pooled standard
on the same slab gel [30–32]. Thus, over 7000 differentially
labelled muscle proteins can be analysed per gel using DIGE
technology, which is far superior to conventional non-
fluorescent methods. In order to prevent the introduction of
potential artefacts due to subcellular fractionation, this study
employed total muscle extracts as starting material for our
comparative proteomic profiling exercise. Consequently, the
aged skeletal muscle protein complement analysed here
represents mostly soluble elements and does therefore not
take into account potential changes in integral receptors and
other insoluble muscle components. Figure 1 illustrates the
representative protein spot pattern in a 2-D gel of Cy2-label-
led pooled standards. The overall distribution of abundant
2-D muscle protein spots was shown to be relatively compa-
rable between Cy3-labelled young adult muscle extracts and
Cy5-labelled senescent muscle extracts (not shown) and
agrees with previously published studies on the skeletal
muscle proteome [25–29, 40–43].
Figure 1. 2-DE analysis of young adult versus senescent skeletal
muscle. Shown is a Cy2-labelled master gel of total protein
extracts from young adult and senescent skeletal muscle. In this
study, the 2-D protein expression pattern of the Cy3-labelled
young adult versus the Cy5-labelled aged soluble skeletal muscle
proteome was investigated. Proteins with a drastically different
expression level are marked by circles and are numbered 1–69.
See Table 1 for a detailed listing of skeletal muscle proteins with a
changed abundance in aged fibres. The pH values of the first di-
mension gel system and molecular mass standards (in kDa) of
the second dimension are indicated on the top and on the left of
the panels, respectively.
3.2 Proteomic profiling of aged gastrocnemius
muscle
Using a Typhoon Trio variable imager and DeCyder 2-D
analysis software, 69 protein species out of 2493 detectable
2-D spots were found to be differentially expressed. Table 1
lists the DIGE-identified proteins that exhibited a drastic
change of expression in aged rat gastrocnemius muscle. Mus-
cle proteins with an age-dependent alteration in abundance
ranged in molecular mass from apparent 15 to 130 kDa and
covered a pI-range from approximately 4 to 9. A decrease in
expression levels was shown for 18 muscle proteins and an
increased concentration was observed for 51 proteins in aged
muscle preparations. Table 1 lists the percentage sequence
coverage achieved by PMF analysis, as well as the relative
molecular mass, pI value, international protein accession
number and fold-change of individual muscle proteins
affected during ageing. In order to be able to correlate pro-
tein spots with an altered density to the list of MS-identified
protein species (Table 1), relevant 2-D spots are shown in the
DIGE Cy2 master gel of the young adult and senescent skel-
etal muscle proteome (Fig. 1). The Cy2-labelled gel with the
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Table 1. List of DIGE-identified proteins that exhibit a drastic change of expression in aged rat gastrocnemius muscle
Spot
no.











1 PK 40.0 57.8 6.6 gi)16757994) 211.21 6.2e-012
2 Unknown protein – – – – 26.65 8.9e-016
3 Pyruvate dehydrogenase 25.9 39.3 6.2 gi)50925725) 25.50 1.9e-006
4 PK 15.0 58.3 6.6 gi)16757994) 22.80 7.1e-010
5 Beta 1 globin 21.8 16.1 8.0 gi)546056) 22.54 5.8e-012
6 PK 15.0 58.3 6.6 gi)16757994) 22.43 1.4e-010
7 Unknown protein – – – – 22.15 5.7e-007
8 Enolase 21.7 47.5 6.2 gi)50926833) 22.14 2.6e-010
9 Myosin binding protein C, fast 31.2 128.3 6.2 gi)62639660) 22.05 6.8e-008
10 Myosin binding protein C, fast 31.2 128.3 6.2 gi)62639660) 22.05 5.6e-009
11 Carbonic anhydrase CAIII 15.4 29.7 6.9 gi)31377484) 22.04 3.9e-009
12 Beta 2 globin 37.7 16.0 8.9 gi)8048915) 22.00 1.0e-009
13 Phosphofructokinase 12.3 86.4 8.7 gi)13929002) 22.00 0.00025
14 Beta 2 globin 59.2 16.0 8.0 gi)984679) 22.00 2.0e-011
15 Unknown protein – – – – 21.95 5.8e-010
16 Beta 1 globin 22.0 16.0 8.2 gi)546056) 21.93 2.2e-009
17 Myosin binding protein C, fast 31.2 128.3 6.2 gi)62639660) 21.91 5.5e-007
18 Unknown protein – – – – 21.91 2.4e-006
19 Myoglobin 26.6 17.2 7.8 gi)11024650) 11.91 1.1e-006
20 Oxoglutarate dehydrogenase 10.0 117.5 6.3 gi)53734284) 11.91 2.9e-011
21 SDH 26.8 72.6 6.8 gi)18426858) 11.92 4.1e-012
22 Troponin T IIIa beta 29.0 29.1 9.0 gi)1256723) 11.92 2.7e-007
23 Phosphoglycerate mutase 30.0 28.7 8.9 gi)8393948) 11.94 1.6e-010
24 Creatine kinase 30.0 43.2 6.6 gi) 66920) 11.95 3.4e-010
25 ATP synthase, a-subunit 33.5 59.9 9.3 gi) 40538742) 12.00 1.2e-008
26 a-Tropomyosin 26.8 32.8 4.7 gi)92921) 12.00 2.2e-008
27 Vdac1 protein 51.2 32.1 8.5 gi)38051979) 12.00 4.7e-009
28 Aldolase 38.0 39.2 8.4 gi)113609) 12.00 4.4e-010
29 Phosphoglucomutase 37.2 61.7 6.1 gi)77627971) 12.00 8.8e-011
30 Troponin T, fast 39.0 30.7 6.2 gi)136385) 12.02 6.3e-007
31 Aldolase 38.0 39.2 8.4 gi)113609) 12.04 4.2e-011
32 Oxoglutarate dehydrogenase 26.6 72.6 6.8 gi)53734284) 12.04 3.1e-011
33 NADH dehydrogenase 16.8 51.4 9.0 gi)54035438) 12.05 3.9e-009
34 Beta globin 37.7 16.0 8.9 gi)984679) 12.06 0.0027
35 ATP synthase, b-subunit 20.1 51.2 4.9 gi)1374715) 12.06 5.8e-010
36 CAP1/DJ-1 protein 42.9 20.2 6.3 gi)3250916) 12.09 1.3e-011
37 Unknown protein – – – – 12.12 8.3e-012
38 ATP synthase, a-subunit 33.5 59.9 9.3 gi) 40538742) 12.12 3.1e-006
39 Triosephosphate isomerase 61.0 27.4 6.5 gi)12621074) 12.12 5.5e-008
40 MLC-2 22.9 36.5 7.0 gi)17105364) 12.14 0.0028
41 Unknown protein – – – – 12.17 1.8e-008
42 Myotilin 11.7 55.5 9.2 gi)34879286) 12.20 1.6e-007
43 Myotilin 11.7 55.5 9.2 gi)34879286) 12.50 5.3e-008
44 Phosphoglycerate kinase 49.4 44.9 8.3 gi)582444) 12.50 2.9e-010
45 Triosephosphate isomerase 68.5 24.2 7.1 gi)12621074) 12.50 4.9e-015
46 Glycerol-3-phosphate dehydro-
genase
10.0 38.1 6.2 gi)57527919) 12.50 2.7e-006
47 Unknown protein – – – – 12.53 1.2e-006
48 Triosephosphate isomerase 68.3 27.4 6.9 gi)12621074) 12.55 7.8e-010
49 IDH 22.0 51.4 9.2 gi)50370082) 12.59 1.6e-011
50 Tripartite motif protein 50 47.6 53.8 5.9 gi)62641355) 12.59 2.2e-008
51 Myoglobin 47.0 18.2 7.8 gi)11024650) 12.59 5.0e-008
52 Unknown protein – – – – 12.61 1.3e-010
53 IDH 22.0 51.4 9.2 gi)50370082) 12.67 4.9e-010
54 Aldehyde reductase 20.6 36.2 6.3 gi)6978491) 12.99 3.0e-010
55 Unknown protein – – 13.05 1.9e-005
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56 CAP1/DJ-1 protein 42.9 20.2 6.3 gi)3250916) 13.09 4.5e-009
57 MLC-2, cardiac 43 18.9 4.8 gi)127167) 13.26 0.0088
58 Unknown protein – – – – 13.37 1.2e-005
59 Heat shock protein Hsp27 43.0 22.8 6.1 gi)204665) 13.73 7.2e-012
60 Unknown protein – – – – 13.78 2.4e-010
61 MDH 26.9 36.6 5.9 gi)37590235) 13.83 6.3e-010
62 Unknown protein – – – – 14.11 3.8e-005
63 aB Crystallin 43.0 20.1 6.8 gi)16905067) 14.31 3.1e-007
64 FABP 27.6 14.8 5.9 gi)30582293) 14.50 1.1e-010
65 a-Actin, cardiac 20.0 42.3 5.2 gi)9885049) 15.58 8.8e-010
66 Unknown protein – – – – 15.90 3.2e-009
67 Adenylate kinase AK1 43.3 21.6 7.7 gi)23831184) 16.71 1.4e-015
68 LDH 21.0 36.9 5.1 gi)8393706) 17.26 6.0e-011
69 MLC-3 43.0 22.3 5.0 gi)6981238) 110.09 1.1e-013
Table shows identification, theoretical molecular mass, theoretical pI, percent sequence coverage, fold-change in expression and t-test
scores for each of the 69 differentially expressed muscle proteins in young adult versus senescent fibres.
mixed standard has marked and numbered all 69 changed
muscle protein spots. The protein species with the highest
fold-decrease was identified as PK (spots 1, 4 and 6). Other
proteins with a drastic decrease in abundance included pyru-
vate dehydrogenase (spot 3), enolase (spot 8), haemoglobin
subunits (spots 5, 12 and 16),myosin binding proteinC (spots
9, 10 and 17), carbonic anhydrase isoform CA3 (spot 11) and
phosphofructokinase (spot 13). In stark contrast, the highest
fold-change increase was observed for myosin light chain
(MLC)-3 (spot 69). The muscle enzymes with the most drastic
upregulation in expression levels were AK (spot 67) and lac-
tate dehydrogenase (LDH, spot 68). Other proteins of
increased density included cardiac a-actin (spot 65), FABP
(spot 64), the small heat shock protein aB-crystallin (spot 63),
MDH (spot 61), heat shock protein Hsp27 (spot 59), cardiac
MLC-2 (spot 57), CAP1/DJ-1 protein (spots 36 and 56), alde-
hyde reductase (spot 54), IDH (spots 49 and 53), tripartite
motif protein 50 (spot 50), myoglobin (spots 19 and 51),
triosephosphate isomerase (spots 39, 45 and 48), glycerol-3-
phosphate dehydrogenase (spot 46), phosphoglycerate kinase
(spot 44), myotilin (spots 42 and 43), MLC-2 (spot 40), ATP
synthase (spots 25, 35 and 38), haemoglobin (spot 34), NADH
dehydrogenase (spot 33), aldolase (spots 28 and 31), phos-
phoglucomutase (spot 29), oxoglutarate dehydrogenase (spots
20 and 32), troponin Tsubunits (spots 22 and 30), Vdac1 pro-
tein (spot 27), a-tropomyosin (spot 26), creatine kinase (spot
24), phosphoglycerate mutase (spot 23) and SDH (spot 21).
3.3 Opposite pathobiochemical fate of PK and AK in
aged muscle
The detailed 2-DE analysis of the above-described DIGE
analysis of young adult versus old muscle revealed a drastic
decrease in the glycolytic marker PK and a concomitant
increase in the enzyme AK. Figures 2 and 3 show expanded
views of the Cy3-, Cy2- and Cy5-labelled 2-D gels and the
comparative graphic presentation of the PK and AK spots,
respectively. The three horizontal rows of protein spots in
Figs. 2A–C represent isoforms of PK, enolase and creatine
kinase. In contrast to the other two enzymes that exhibit only
small changes in abundance, the central PK-containing 2-D
spot in the top row is drastically reduced (Fig. 2C). This
finding is illustrated in the graphic comparison of spot
intensity in Figs. 2D–F. The concentration of the key glyco-
lytic enzyme PK, which is involved in the final substrate-level
phosphorylation reaction of the oxidoreduction-phosphoryl-
ation step of the muscle glycolysis pathway, is substantially
lower in Cy5-labelled old muscle samples as compared to
Cy3-labelled young adult specimens. The opposite result was
shown for the AK1 isoform of AK, an important enzyme of
nucleotide metabolism that converts two nucleoside diphos-
phates into a nucleotide triphosphate and a nucleoside
monophosphate. The expanded DIGE gel expression pattern
in Figs. 3A–C clearly shows the increased density of the AK1-
containing spot in old muscle preparations. This result is il-
lustrated in the graphic presentation of 2-D spot intensity in
Figs. 3D–F. Senescent skeletal muscle fibres appear to show
a clear pattern of decreased and increased enzyme con-
centrations, whereby the opposite fate of PK and AK is a
striking combination of altered expression levels.
3.4 Immunoblotting survey of biomarkers of muscle
ageing
2-D immunoblotting of selected muscle proteins, which have
been implicated by the above-described DIGE analysis to be
changed in their expression level during ageing, has been
conducted with a library of highly specific antibodies.
© 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.proteomics-journal.com
Proteomics 2008, 8, 364–377 Animal Proteomics 371
Figure 2. Decreased expression of PK in
aged skeletal muscle. Shown is an
expanded view of 2-D gels of the Cy3-
labelled young adult muscle proteome
(A), the Cy2-labelled pooled standard (B)
and the Cy5-labelled senescent muscle
proteome (C), as well as the comparative
graphic representation of the PK spot
(D–F), which clearly demonstrates the
increased expression levels of the en-
zyme PK in aged fibres. The position of
the 2-D spot rows that represent PK,
enolase and creatine kinase is indicated
by arrowheads on the left. The portion of
the 2-D gel (see Fig. 1) shown covers the
range of approximately pH 6–8 in the
first dimension and a molecular mass
range of approximately 30–60 kDa in the
second dimension.
Figure 3. Increased expression of AK in aged skeletal muscle.
Shown is an expanded view of 2-D gels of the Cy3-labelled young
adult muscle proteome (A), the Cy2-labelled pooled standard (B)
and the Cy5-labelled senescent muscle proteome (C), as well as
the comparative graphic representation of the AK1 spot (D–F),
which clearly demonstrates the decreased expression levels of
the enzyme AK in aged fibres. For comparative purposes, the
major 2-D spot representing carbonic anhydrase (CA3) is marked.
The portion of the 2-D gel (see Fig. 1) shown covers the range of
approximately pH 7–8 in the first dimension and a molecular
mass range of approximately 20–30 kDa in the second dimen-
sion.
Besides 3-month- and 30-month-old specimens, also 6-
month-old muscle preparations were used for this immuno-
blot analysis. Therefore, the survey covered the age groups of
young adult, adult and senescent fibres. As illustrated in the
representative immunoblots of Figs. 4A–R, the altered pro-
tein expression patterns as determined by DIGE analysis
(Figs. 1–3) were confirmed by antibody labelling of key
muscle proteins. The three immuno-decorated protein spots
representing PK showed approximately the same modified
abundance pattern as the Cy-dye labelled difference gels
(Figs. 2A, C). The two more acidic PK-protein species, espe-
cially the 2-D spot in the middle, exhibited a drastic age-
related decrease (Figs. 4A–C). The observed higher con-
centration of the cytosolic marker enzyme LDH in aged
muscle was also shown by immunoblot analysis (Figs. 4D–
F). A shift to more aerobic-oxidative metabolism during age-
ing was indicated by the increased abundance of the FABP
(Figs. 4G–I) and the higher amount of the mitochondrial
marker enzymes SDH, IDH and MDH (Figs. 4J–R). Since
2-D labelling of AK resulted in high background staining, 1-
D immunoblotting was carried out for this key muscle en-
zyme. Figure 5 confirmed a substantial increase in this en-
zyme in senescent fibres. While the Coomassie-stained pro-
tein pattern showed a relatively comparable overall protein
band composition during muscle ageing (Fig. 5A), the
immuno-decoration of AK was considerably more intense in
30-month-old fibres, as compared to 3- or 6-month-old spe-
cimens (Fig. 5B).
3.5 Immunofluorescence localization of PK in aged
muscle fibres
Confocal laser scanning microscopy was employed to inves-
tigate the subcellular fate of PK in aged muscle fibres. The
results from the above-outlined proteomic DIGE analysis
and the immunoblot analysis of this enzyme were confirmed
by immunofluorescence microscopy. Antigen labelling with
Alexa Fluor 488 dye-conjugated secondary antibodies to pri-
mary anti-PK antibodies illustrated the decreased cytosolic
abundance of PK in aged muscle as compared to young adult
fibres (Figs. 6C, F–H). The position of the surface membrane
and nuclei was marked by red fluorescence labelling for the
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Figure 4. 2-D immunoblotting survey of PK and other keymuscle
proteins with a differential expression pattern in aged fibres.
Shown is an expanded view of immuno-decorated 2-D spots
representing PK (A–C), LDH (D–F), FABP (G–I), SDH (J–L), IDH (M–
O) and MDH (P–R). Lanes 1–3 represent total extracts from 3-
month- (young adult), 6-month- (adult) and 30-month-old
(senescent) skeletal muscle fibres, respectively. The position of
immuno-decorated spots is marked by arrowheads.
Figure 5. 1-D immunoblot analysis of AK in aged fibres. Shown is
a Commassie-stained gel of crude muscle preparations (A) and
an NC replica labelled with an antibody to AK (B). Lanes 1–3
represent the electrophoretically separated muscle protein com-
plement from 3-, 6- and 30-month-old rats, respectively. The
position of the immuno-decorated AK band is marked by an
arrowhead. Molecular mass standards (in kDa) are indicated on
the left of the panels.
Figure 6. Immunofluorescence localization of PK in aged fibres.
Shown is the confocal laser scanningmicroscopical analysis of 3-
month-old (A–C; G) versus 30-month-old (D–F; H) transverse rat
muscle cryosections. The sarcolemmal marker b-dystroglycan (b-
DG; A, D, G, H) and the enzyme PK (C, F, G, H) were labelled with
antibody-conjugated Alexa Fluor 594 dye and Alexa Fluor 488
dye, respectively. The position of nuclei within skeletal muscle
fibres was marked by the DNA-binding dye DAPI (B, E, G, H).
Panels A–F show individual fluorescence images, while panels G
and H show combined fluorescence images. Bar equals 40 mm.
sarcolemmal glycoprotein b-dystroglycan (Figs. 6A, D, G, H)
and blue fluorescence labelling with the DNA-binding dye
DAPI (Figs. 4B, E, G, H), respectively.
4 Discussion
The drastic loss of skeletal muscle mass and strength in old
age, now generally referred to as sarcopenia, is a major factor
in blocking healthy ageing [6]. However, in both humans and
animal models, the capacity to improve skeletal muscle mass
and strength with training is preserved [48, 49]. Although a
complex relationship exists between sarcopenia, nutrition
and other age-induced pathologies [50], it is promising that
resistance exercise training can partially reverse muscle
weakness in the elderly [51]. One major problem with devel-
oping new intervention strategies for sarcopenia is to over-
come age-dependent metabolic impairments. Despite the
fact that protein-calorie supplements have been shown to be
helpful to counteract the loss of skeletal muscle mass [50],
elderly patients display a reduced sensitivity towards stimu-
lating protein synthesis from nutritional intake [52]. Thus,
physical exercise in combination with nutritional interven-
tion is useful, but on its own is probably not sufficient to treat
severe muscle wasting in the aged human. Additional phar-
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macological treatments that interfere with hormonal and
metabolic deficiencies might be essential to counteract the
overall muscle impairments seen in sarcopenia. In this
respect, studying molecular and cellular aspects of the mus-
cle ageing process may help to develop the basis of evidence
for decisively improving public health strategies to promote
healthy ageing. The systematic cataloguing of sarcopenia-
associated biomarkers is an excellent starting point for the
design of more elaborate experimental and clinical studies.
In the long-term, proteomic data might be useful for the
development of novel therapeutic approaches that prevent or
at least minimize age-related impairments and thereby pro-
mote improved longevity.
Animal model proteomics is widely employed in the
initial identification of novel disease markers [14]. A crucial
issue in animal model research is whether a genetically
engineered or spontaneous animal strain replicates key
pathological features of a human disease process with
respect to severity, sequence of symptoms and complexity.
An established animal model of sarcopenia is aged rat mus-
cle [16–18], whereby a certain degree of strain-specific differ-
ences appears to exist between the main ageing models, e.g.
the Fischer F344/N, Fischer F344/NXBN Brown Norway,
WI/HicksCar or Wistar rat [53, 54]. In both, senescent hu-
man muscle and aged rodent muscle, the process of fibre
regeneration is impaired and seems to play a key role in the
loss of muscle mass [55–57]. Although 30-month-old Wistar
gastrocnemius muscle is not a perfect replica of all aspects of
the human pathology, this animal model exhibits many cel-
lular, histological and functional alterations seen in senes-
cent patients. In the aged rat, fibre numbers, fibre size and
fibre type proportions are changed [58, 59] and abnormal
cellular features include a higher frequency of longitudinal
splitting and fibre degeneration [60]. Impaired contractile
properties of both fast and slow muscle relate to the reduced
speed of isometric contraction in aged rats [58]. Denervation–
reinnervation cycles result in the incomplete recruitment of
aged fibres [61] and are associated with the loss of whole
motor units [59]. A comparative physiological study has
shown that aged rat fibres are not able to properly adapt to
repetitive mechanical loading [62], making 30-month-old rat
muscle a suitable model system to investigate the effect of
ageing on skeletal muscle tissue.
This proteomic study of the aged rat muscle model of
sarcopenia has discovered a large cohort of new biomarkers
of muscle ageing including opposite changes in two key
metabolic enzymes, PK and AK. The differential expression
of a large number of glycolytic and mitochondrial enzymes
such as enolase, aldolase, phosphoglycerate kinase, phos-
phofructokinase, phosphoglycerate kinase, triosephosphate
isomerase, glycerol-3-phosphate dehydrogenase, LDH, ATP
synthase, SDH, MDH and IDH in aged muscle are also
interesting findings with respect to understanding metabolic
changes in senescent fibres [3]. The observed increase in the
oxygen-transporter myoglobin and FABP during muscle
ageing perfectly agrees with the previously reported shift of
older fibre populations to aerobic-oxidative metabolism and
slower twitching activity [5]. Upregulation of myotilin and
aB-crystallin suggests filament remodelling and autoprotec-
tive mechanisms in aged muscle [63]. These detailed prote-
omic findings, achieved by the application of one of the most
sensitive comparative approaches available in modern bio-
chemical analysis, are useful for determining the biological
mechanisms involved in ageing and might thus lead to the
design of improved diagnostic procedures and/or ther-
apeutic strategies to counteract ageing-induced muscle
degeneration.
Oxygen transport and storage plays an essential role in
skeletal muscle metabolism. The proteomic profiling of aged
muscle suggests a decrease in haemoglobin and an increase
in myoglobin. While haemoglobin, which forms in its adult
form mostly a a2b2-configuration, is present in high con-
centration in erythrocytes, myoglobin is a sarcoplasmic oxy-
gen-carrier that exists as a single polypeptide chain in its
functional form [64]. All major haemoglobin spots in the
lower right corner of the DIGE master gel showed a decrease,
with the exception of one minor 2-D spot, which agrees with
a disturbed microcirculation in aged fibres [35]. In contrast,
the upregulation of myoglobin supports the idea that aged
fibre metabolism shifts to a more aerobic-oxidative mode.
While fat and connective tissue increases in the muscle belly
of older individuals, muscle fibres of both type I and II are
lost during ageing. However, as reviewed by Vandervoort [5],
all large-scale histochemical studies have shown a con-
siderably higher loss in type II fibres as compared to type I
fibres, agreeing with a slowing of muscle contractile proper-
ties in aged muscles. Since denervation and reinnervation
processes occur during muscle ageing, a complex pattern of
motor unit alterations can be observed in sarcopenia [33].
Since increased levels of mitochondrial fatty acid oxida-
tion in a slower-twitching fibre population would require an
altered degree of fuel supply, the increase in the FABP is
compatible with the previously described fibre type transfor-
mation during ageing [5]. Both, FABP and myoglobin can be
considered limiting factors of aerobic-oxidative metabolism
in slow-twitch fibres [65] and have previously been shown to
increase in abundance during fast-to-slow fibre transition
processes [42]. Because aerobic metabolism increases oxygen
consumption, which in turn may generate ROS that inhibit
enzymes such as oxoglutarate dehydrogenase in skeletal
muscle [66], the increased abundance of this mitochondrial
enzyme may reflect a compensatory mechanism in aged
fibres. Since the CAP1/DJ-1-protein might also be involved
in the cellular response to oxidative stress [67], its increase is
in line with an increased oxygen supply to the aged fibre
population. In contrast to the enhanced sarcoplasmic oxy-
gen-transport system, the CO2-removal mechanism appears
to be impaired in sarcopenia. Removal of CO2 is provided by
its conversion into carbonic acid by the enzyme carbonic
anhydrase [68]. The reduced expression of the muscle-spe-
cific isoform CA3 of carbonic anhydrase indicates a reduced
availability of this essential hydration reaction and may
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induce pathological levels of CO2 in aged fibres. On the other
hand, since the CA3 isoform was shown to be present at a
higher density in type I fibres [69], the increased level of this
enzyme may simply reflect the age-induced shift to a larger
proportion of slow fibres in sarcopenia.
The previously described transition to aerobic-oxidative
metabolism in aged fibres with slower contractile properties
[5] agrees with the differential expression pattern of many
glycolytic and mitochondrial markers in aged muscle. How-
ever, the transformation process is more complex as com-
pared to fast-to-slow fibre transitions under conditions of
maximum activity [8, 42]. Besides transdifferentiation due to
altered neuromuscular activity patterns, aged muscles also
undergo denervation–reinnervation phases triggering fibre
atrophy and regeneration cycles with altered motor unit
arrangements [37, 70, 71]. This might explain the disturbed
expression pattern of myosin, actin, troponin and tropomyo-
sin isoforms, as well as the differential effect on glycolytic
enzymes. The glycolytic pathway may be divided in the
priming stage, the splitting stage and the oxidoreduction-
phosphorylation stage of glucose utilization for the produc-
tion of ATP [72]. The proteomic profile of age-induced chan-
ges in muscle metabolism showed a drastic decrease in eno-
lase, phosphofructokinase and PK, but increases in triose-
phosphate isomerase, aldolase, phosphoglycerate kinase,
glycerol-3-phosphate dehydrogenase and LDH. On the other
hand, pyruvate dehydrogenase, the enzyme responsible for
the conversion of pyruvate to acetyl-CoA during aerobic gly-
colysis, is decreased. The expression levels of mitochondrial
markers of the citric acid cycle, such as MDH, IDH and
SDH, were all shown to be elevated. This agrees with a shift
to aerobic-oxidative metabolism [5]. The finding that the a-
and b-subunits of the mitochondrial ATP synthase are up-
regulated in aged fibres also suggests an increased level of
mitochondria in the overall aged fibre population [36]. The
altered expression of AK and creatine kinase in senescent
muscle suggests a disturbed nucleotide metabolism in sar-
copenia. Since the transfer of energy from high-energy
bonds between different metabolites plays a crucial role in
skeletal muscle, the increased AK1 levels may represent a
compensatory mechanism of aged fibre energy metabolism.
Skeletal muscle degeneration and fibre type shifting
causes enormous cellular stress, which usually triggers the
increased synthesis of stress elements and chaperones [73].
It is therefore not surprising that the muscle-specific small
heat shock proteins Hsp27 and aB-crystallin are up-regu-
lated during the age-induced stress response in skeletal
muscle [74]. In addition, important structural elements that
control sarcomeric integrity, such as myotilin and myosin
binding protein C, are also increased in an age-dependent
fashion. Small stress proteins containing a crystallin-domain
are mostly involved in filament repair and the prevention of
deleterious protein aggregation [75, 76]. Hence, increased
levels of aB-crystallin and Hsp27 appear to be an autopro-
tective mechanism for the rescue of damaged muscle fibres
during ageing [74]. Myotilin is a thin filament-associated
protein that plays a crucial role in protein complex formation
at the Z-disc [77]. Myosin binding protein C supports myosin
polymerization in the thick filament [78]. The drastic
increase in both sarcomeric support elements seems to be in
response to filament restructuring during the ageing pro-
cess.
In conclusion, the MS-based proteomic screening of
aged rat gastrocnemius muscle shown here agrees with pre-
vious studies [23, 24], supports the idea that sarcopenia is a
multifactorial disease [3–6], and has identified several new
biomarkers or interesting novel biomarker combinations for
the evaluation of sarcopenia of old age. This includes drastic
changes in the expression levels of key glycolytic and mito-
chondrial enzymes, the upregulation of the small stress pro-
teins aB-crystallin and Hsp27, an increase in the sarcomeric
elements myotilin and myosin binding protein C, alterations
in contractile proteins, and the upregulation of myoglobin
and FABP. Based on these proteomic findings, more refined
physiological, biochemical and cell biological studies can be
designed to further our understanding of the molecular
pathogenesis of age-related skeletal muscle wasting.
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